abstract |
This invention relates to aerosol formulations of use for the administration ofnmedicaments by inhalation, in particular a pharmaceutical aerosol formulation whichncomprises particulate medicament selected from the group comprising salmeterol,nsalbutamol, fluticasone propionate, beclomethasone dipropionate and physiologicallynacceptable salts and solvates thereof and a fluorocarbon or hydrogen-containingnchlorofluorocarbon propellant, which formulation is substantially free of surfactant. n A method of treating respiratory disorders which comprises administration byninhalation of an effective amount of a pharmaceutical aerosol formulation as defined isnalso described. |